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Abstract
Background: Diagnosing serious infections in children is challenging, because of the low incidence of such
infections and their non-specific presentation early in the course of illness. Prediction rules are promoted as a
means to improve recognition of serious infections. A recent systematic review identified seven clinical prediction
rules, of which only one had been prospectively validated, calling into question their appropriateness for clinical
practice. We aimed to examine the diagnostic accuracy of these rules in multiple ambulatory care populations in
Europe.
Methods: Four clinical prediction rules and two national guidelines, based on signs and symptoms, were validated
retrospectively in seven individual patient datasets from primary care and emergency departments, comprising
11,023 children from the UK, the Netherlands, and Belgium. The accuracy of each rule was tested, with pre-test and
post-test probabilities displayed using dumbbell plots, with serious infection settings stratified as low prevalence
(LP; <5%), intermediate prevalence (IP; 5 to 20%), and high prevalence (HP; >20%) . In LP and IP settings, sensitivity
should be >90% for effective ruling out infection.
Results: In LP settings, a five-stage decision tree and a pneumonia rule had sensitivities of >90% (at a negative
likelihood ratio (NLR) of < 0.2) for ruling out serious infections, whereas the sensitivities of a meningitis rule and
the Yale Observation Scale (YOS) varied widely, between 33 and 100%. In IP settings, the five-stage decision tree,
the pneumonia rule, and YOS had sensitivities between 22 and 88%, with NLR ranging from 0.3 to 0.8. In an HP
setting, the five-stage decision tree provided a sensitivity of 23%. In LP or IP settings, the sensitivities of the
National Institute for Clinical Excellence guideline for feverish illness and the Dutch College of General Practitioners
alarm symptoms ranged from 81 to 100%.
Conclusions: None of the clinical prediction rules examined in this study provided perfect diagnostic accuracy. In
LP or IP settings, prediction rules and evidence-based guidelines had high sensitivity, providing promising rule-out
value for serious infections in these datasets, although all had a percentage of residual uncertainty. Additional
clinical assessment or testing such as point-of-care laboratory tests may be needed to increase clinical certainty.
None of the prediction rules identified seemed to be valuable for HP settings such as emergency departments.
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Background
Acute infection is the most common presentation in chil-
dren attending settings of ambulatory care (AC) [1,2].
Although most infections are self-limiting, they remain
an important cause of morbidity and mortality in chil-
dren in economically developed countries [3-5]. In the
UK, infections account for 20% of childhood deaths,
especially in children under 5 years of age [6]. Serious
infections in children are usually defined as sepsis
(including bacteremia), meningitis, pneumonia, osteo-
myelitis, cellulitis, and complicated urinary-tract infec-
tion (UTI; positive urine culture combined with systemic
features such as fever) [3]. As a result of immunization
against Haemophilus influenzae and Streptococcus pneu-
moniae, the incidence of these diseases has decreased
steadily over recent decades, and they are now estimated
to account for less than 1% of all acute childhood infec-
tions in primary care (PC) [2,7].
The combination of low incidence, non-specific initial
clinical presentation, and potential for rapid deterioration
makes the assessment of acutely ill children difficult
[8,9]. Clinical prediction rules (CPRs) and guidelines may
assist in the early recognition of serious infections [3]. In
a previous systematic review, we identified all available
CPRs (seven in total), based on signs and symptoms, for
identifying any serious infection (two rules), pneumonia
(two), meningitis (two), and dehydration from gastroen-
teritis (one rule) in AC settings [3]. Four of these seven
CPRs were derived for use in emergency-care settings
and their applicability in PC and AC settings has not
been confirmed.
Only one rule, the Yale Observation Scale (YOS) [10]
has been prospectively assessed in four studies [11-14], of
which only two assessed the YOS in the intended age
group of 3 to 36 months [12,14]. We also identified two
national guidelines for the assessment of feverish children
(Guideline on Feverish Illness in Children by the
National Institute for Health and Clinical Excellence
(NICE) [15] and the guidelines from the Dutch College
of General Practitioners (NHG) [16]). A focused litera-
ture search identified an additional CPR published after
this review: an emergency-department (ED) rule [17] to
diagnose pneumonia, UTI, or bacteremia (see Additional
file 1).
Although some of these guidelines (NICE guidelines,
NHG alarm symptoms) are often used in clinical practice,
very little external validation to support their use in prac-
tice has been performed in new and independent popula-
tions [18]. This raises questions about the robustness of
the rules and their generalizability.
The aim of this study was to examine the diagnostic
accuracy both of the CPRs identified by the systematic
review and of the evidence-based guidelines, using retro-
spective external validations on individual patient datasets
from ambulatory pediatric settings including PC and ED
settings from three European countries.
Methods
Identification of datasets
We included datasets from studies identified in the sys-
tematic review [3], which had been published within the
past 10 years, and from expert contacts. The criteria used
to select datasets (Table 1), were design (cohort studies
that enrolled children consecutively), sample size (> 500
children), participants (children aged 0 to 18 years or
subgroups of these), setting (AC defined as general or
family practice, pediatric outpatient clinics, pediatric
assessment units, or EDs in developed countries), out-
come (serious infection), and data availability (agreement
to share data) (Figure 1).
Ethics approval
This research conformed to the Helsinki Declaration
and to local legislation. The study authors, agreeing to
share data, obtained ethics approval from their regional
research ethics committees before the study for the
initial data collection of the included datasets.
Processing of included datasets
Direct access to the raw data of each dataset was granted
and key characteristics of each of the datasets were
extracted (Table 2). The variables used in each dataset
were translated to English if necessary, and the transla-
tion, coding, and definition of variables were clarified
with the authors of the relevant study.
We used the following criteria to determine which
dataset could be used to validate each CPR and guide-
line, and which diagnoses should be included in the
composite outcome of serious infection.
• Datasets used to derive a CPR were not used to vali-
date the same rule.
• When variables were not entirely identical with the
variables of the original CPR, we identified proxies where
possible. For example, the variable ‘dyspnea’ of the five-
stage decision tree (FSDT) and the pneumonia rule was
not recorded in three datasets; we therefore used either
‘respiratory distress’ or ‘chest flaring’ as a proxy (for a full
list of all approximations, see Additional file 2 and Addi-
tional file 3).
• Based on the number of required variables, when-
ever one-third or more (fever guidelines), one or more
(pneumonia rule, meningitis rule) or two or more (YOS,
FSDT) of the required variables were not recorded, that
dataset was not used for validation of that specific rule.
We performed sensitivity analyses as described below.
• Missing data on variables used in the validation were
not imputed because the necessary missing-at-random
assumption was likely to be incorrect because some of
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the datasets consisted of routinely collected data from
medical records.
• Apart from the approximations used (see Additional
files 2, Additional file 3), no alterations of the original
data were performed. We report the number of observa-
tions available for analysis of each prediction rule after
applying these assumptions.
• In contrast to the other dichotomous rules, the YOS
generates a sum score. We defined an abnormal result
using two pre-selected cut-offs (of 8 or 10).
• Serious infection was defined as sepsis (including
bacteremia), meningitis, pneumonia, osteomyelitis, cellu-
litis, or complicated UTI [3]. These diagnoses were
available for all datasets, and assessment of the diag-
noses to ensure comparability of outcomes was dis-
cussed with the authors of each study.
The settings in the included datasets were stratified as
having low prevalence (LP; 0 to 5%), intermediate preva-
lence (IP; 5 to 20%) or high prevalence (HP; >20%) of the
serious infection(s) of interest (including all serious infec-
tions, pneumonia, meningitis) with the clinical assumption
that diagnostic goals are different in each setting. In LP
settings, CPRs should have high sensitivity in order to cor-
rectly rule out (at a negative likelihood ratio (NLR) of up
to 0.2) the target disorder(s) at a reasonable cost in terms
of referral or admission rates [19,20].
The accuracy of the CPRs was assessed retrospectively in
each of the available prospectively collected datasets by
calculating sensitivity, specificity, predictive value, and
likelihood ratio (LR). We used dumbbell plots to display
the change from pre-test to post-test probabilities [3].
To avoid the risk of influencing diagnostic accuracy by
either an arbitrarily chosen number of required variables,
or the age range available in each dataset compared with
the intended age range of the rule, we performed the
following sensitivity analyses after obtaining initial results
with the different CPRs. Firstly, when a CPR was specifi-
cally designed for a certain age group (, for example, the
YOS for children aged 3 to 36 months and the NICE
guidelines for children up to 5 years of age), we compared
the 95% confidence intervals (CIs) of the diagnostic char-
acteristics (sensitivity, specificity, LRs and area under the
curve (AUC)) [21] in the target age group with the entire
age range of the dataset at hand. Second, when one or
more variables of the original prediction rule were missing,
we examined those same diagnostic characteristics in the
datasets with no missing variables, to avoid biasing results
on the number of missing variables. Whenever more than
one (for the CPRs) or more than two (for the fever guide-
lines) original variables were missing, we did not perform
sensitivity analysis, based on the rationale that missing two
(or more) of a maximum of six variables (for the CPRs) or
three (or more) of a maximum of eight original variables
(for the fever guidelines) did not seem clinically sensible.
This was discussed and confirmed by all study authors,
contributing data to the current study.
Meta-analysis of the pooled results of the multiple exter-
nal validations was not possible because substantial clinical
heterogeneity was found in these datasets, including differ-
ences in setting, inclusion criteria, immunization schedules,
and definition of serious infection. Additionally, the small
number of included studies would have led to a high level
of uncertainty in the estimates of the variances of the ran-
dom effects for both the bivariate and hierarchical summary
receiver operating characteristic models, if heterogeneity
were to be explored statistically. Inclusion or exclusion of a
single study would affect the convergence of the model
greatly [21]. The individual patient data were analyzed in
every dataset separately. The translation, re-coding, and
data checking were performed by one author (JV), and the
Table 1 Criteria for inclusion and exclusion of datasets in validation analysis.
Characteristic Inclusion Exclusion
Publication
date
Studies published in the past 10 years Studies published before 2003
Design Studies that had recorded clinical features; prospective or retrospective cohort
study design
Unclear methods
Sample Size > 500 children < 500 children
Participants Age between 1 month and 18 years of age; studies including children spanning
this age range were included if they reported age (or age could be calculated)
Children with congenital or obtained
immunodeficiency. Age outside the required
range
Setting Ambulatory care (defined as general or family practice, pediatric outpatient
clinics, pediatric assessment units, or emergency departments). Developed
countries, defined using the United Nations list, which included Europe, Canada,
USA, Australia, New Zealand and Japan
Studies conducted in developing countries
Outcome Serious infection, defined as sepsis (including bacteremia), meningitis, pneumonia,
osteomyelitis, cellulitis, and complicated urinary-tract infection (positive urine
culture and systemic effects such as fever)
Diagnosis other than serious infection
Data
availability
Agreement to share data
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results of each step were discussed with all of the other
authors. All analyses were performed with Stata software
(version 11.2; Stata Corp., College Station, TX, USA).
Results
Included datasets
We obtained seven datasets providing data on 11,023 chil-
dren: two LP datasets from general practice [7,22], two IP
datasets from EDs [23,24] and three HP datasets from EDs
[25,26] or pediatric assessment unit s[18] in the UK (n =
2), the Netherlands (n = 4) and Belgium (n = 1) (Figure 1,
Table 2). Children were included based on presence of
fever [22,24,25], acute illness [7,23], or acute infection
[18], or on referral for meningeal signs [26]. Children with
various co-morbidities were excluded in six studies, and
one study excluded children who required immediate
resuscitation. The outcome in all studies included sepsis,
meningitis, pneumonia, and complicated UTI as part of
the outcome variables. Osteomyelitis and cellulitis were
explicitly mentioned in five and three datasets, respec-
tively. The mean age ranged from 0.94 to 5.0 years, and
prevalence of serious infection ranged from 0.8 to 43.8%.
Clinical predictors included in the datasets
Most datasets included basic demographic characteris-
tics such as age, duration, and severity of illness, as well
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Figure 1 Flowchart of dataset inclusion.
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Table 2 Characteristics of datasets used for external validation of prediction rules.
Dataset Setting Country N Age,
years;
mean
(range)
Prevalence
ofserious
infection %
(95% CI)
Inclusion criteria Exclusion criteria
Van den
Bruel et al.
2007 [7]
GP/AP/
ED
BE 4102 5.0 (0.0 to
16.9)
0.8 (0.5 to 1.1) Children ≤16 years with acute illness max 5
days
Traumatic or neurological illness, intoxication, psychiatric or behavioral
problems without somatic cause or an exacerbation of a chronic condition.
No repeated inclusion of same infant within 5 days. Exclusion of physicians if
the assumption of consecutive inclusion was probably violated
Roukema et
al. 2008 [24]
ED NL 1750 2.9 (0.1 to
15.7)
12.3 (10.8 to 13.9) All children with fever (>38°C) at ED, without
meningeal irritation
Chronic disease, Immunodeficiency
Bleeker et al.
2007 [25]
ED NL 595 0.9 (0.0 to
3.0)
23.0 (19.6 to 26.4) Children with fever T>38°C at ED, no clear
focus identified after evaluation GP of history
by pediatrician
Chronic disease, Immunodeficiency
Monteny et
al. 2008 [22]
GP NL 506 2.2 (0.3 to
5.9)
4.0 (2.3 to 5.7) Children aged 3 months to 6 years,
contacting a GP cooperative after hours with
fever as the presenting symptom
Language barriers, no repeated inclusion within the previous two weeks
Brent et al.
2011 [23]
ED UK 2777 3.3 (0.0 to
18.4)
5.3 (4.5 to 6.1) All children presenting with a medical
problem to the pediatric emergency-care unit
whatever their age
Children who required immediate resuscitation. Comorbidity and chronic
illness
Thompson
et al. 2009
[18]
PAU UK 700 4.6 (0.0 to
16.0)
37.7 (34.1 to 41.3) Children aged 3 months to 16 years with
suspected acute infection
Children with diseases liable to cause repeated serious bacterial infection,
and infections resulting from penetrating trauma
Oostenbrink
et al. 2004
[26]
ED NL 593 3.7 (0.1 to
16.1)
43.8 (39.8 to 47.9) Children aged 1 month to 16 years,
meningeal signs at GP, pediatrician-referred
or self-referred with neck pain
Comorbidity, ventriculoperitoneal drain
AP, ambulatory pediatric care; BE, Belgium; CI, confidence interval; ED, emergency department; GP, general practice; NL, the Netherlands; PAU, pediatric assessment unit; UK, United Kingdom.
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as referral status. Temperature was recorded in all data-
sets (with missing data rates ranging from 0 to 18%),
heart rate in five datasets (missing in 2 to 48%), capillary
refill time in five (missing in 2 to 48%), respiratory rate
in four (missing in 15 to 53%), and oxygen saturation in
four (missing in 4 to 74%).
Validation of the FSDT [7] was possible in five data-
sets [18,22-25], of which four had all variables present
using ‘clinical sick impression’ as a proxy for ‘physician’s
gut feeling that something is wrong’, and ‘respiratory
distress’ or ‘chest flaring’ as a proxy for ‘dyspnea’ (See
Additional file 2). Because the variable ‘diarrhea’ was
missing in one dataset [25], we performed a sensitivity
analysis comparing the results of the four remaining
variables, as noted below.
Five datasets [18,22-25] were available for one pneu-
monia rule [7], developed in PC settings, with ‘sick
impression to clinician’ as a proxy for the ‘physician’s
gut feeling that something is wrong’ and ‘nasal flaring’
for ‘dyspnea’. A second pneumonia rule, derived in the
same dataset [7], which included ‘respiratory distress’
and ‘parental concern the illness is different’ could not
be validated, as the latter variable was not recorded in
any of the validation datasets.
A meningitis rule, derived by Offringa et al. [27] for
children in the ED, was validated in three datasets
[7,18,26]. Because all items except ‘nuchal rigidity’ were
present in one additional dataset [23], we performed a
sensitivity analysis comparing the results of the two
remaining variables, eventually excluding this dataset
from the analysis, as noted below. A second meningitis
rule could not be validated because the absence of its
key variables in these datasets [28].
For the YOS [10], developed in secondary care, three
datasets had recorded variables used in the original Yale
scoring [18,22,23] (see Additional file 2). Because the
YOS item ‘reaction to parent stimulation’ was missing in
one dataset [29], we performed a sensitivity analysis com-
paring the results of the five remaining YOS items, as
noted below. None of the datasets included sufficient
variables to validate the prediction rule to identify gastro-
enteritis with dehydration developed by Gorelick et al.
[30], or the prediction rule developed by Craig et al. [17].
The NICE guideline for feverish illness in children and
the NHG alarm symptoms [15,16] were validated in four
[18,22,23,26] and five [7,18,22,23,26] datasets, respectively.
Validation results
The characteristics of diagnostic accuracy, according to
prevalence, are shown for all CPRs (Figure 2, Figure 3).
Low-prevalence settings
The FSDT had a sensitivity of 90% (95% CI 68 to 99%)
and an NLR of 0.2 (95% CI 0.1 to 0.9) in the single LP
dataset available for validation, with false-positive test
results (for example, no serious infection present) in
54% of all children examined [22]. The sensitivities of
the pneumonia rule were 94% (95% CI 71 to 100%)
and 92% (95% CI 86 to 96%) in two datasets, with
NLRs of less than 0.2, resulting in 54% and 56% false-
positive test results [22,23]. Validation of the meningi-
tis rule in two LP datasets [7,18] resulted in sensitiv-
ities ranging from 33% (PC dataset) to 100%
(secondary care dataset with a LP for meningitis) with
NLRs ranging from 0.1 to 0.7. The YOS, with cut-offs
of 8 and 10, provided sensitivities below 46% in one
LP dataset [22], but had an NLR of greater than 0.6.
The NICE ‘traffic light’ system with any amber or red
sign present, and the NHG alarm symptoms were
extremely sensitive (100%) with NLR of greater than
0.4, testing as false positive in 90 to 95% of all children
in one LP dataset [22].
Intermediate-prevalence settings
The FSDT provided moderate sensitivities of 76% (95%
CI 69 to 81%) and 88% (95% CI 82 to 93%), in two IP
settings [23,24] (with NLR ranging from 0.3 to 0.7). The
pneumonia rule had sensitivities ranging from 66 to
82% in two datasets [24,25] but in a third dataset [18]
with the highest prevalence (11%) of pneumonia, the
sensitivity was only 27% (95% CI 17 to 39%) and the
NLR was 0.8 (95% CI 0.7 to 1.0). The YOS, with cut-off
values of 8 and 10, provided sensitivities of less than
41% in one IP dataset [23], and had an NLR greater
than 0.7. Finally, the NICE guideline and NHG alarm
symptoms had high sensitivity (97 to 100%) in one IP
setting [23] with NLR of less than 0.1.
High-prevalence settings
In one HP setting [25], the FSDT had a sensitivity of
89% (95% CI 83 to 94%) with NLR of 0.4 (95% CI 0.2 to
0.6). However, sensitivity was only 23% (95% CI 18 to
29%) with NLR of 0.8 (95% CI 0.7 to 0.9) in a pediatric
assessment unit [18]. In one study [26] that included
children with meningeal signs identified by the referring
physician, the meningitis rule showed high sensitivity, at
96% (95% CI 92 to 98%) and NLR of 0.1 (95% CI 0.04
to 0.2). The Yale score, with cut-offs of 8 and 10, pro-
vided sensitivities of less than 30% in one HP dataset
[18], and NLR of 0.9. Finally, both NICE guideline and
NHG alarm symptoms had sensitivities ranging from 87
to 99% in two HP datasets [18,26] with NLR greater
than 0.4.
Sensitivity analyses
Comparing the 95% CIs, we found similar results for the
diagnostic characteristics of the YOS and the NICE
guidelines in children of all ages as well as in children for
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clinical prediction rule dataset n/Na  % test positiveb % sensitivity (95% CI) % specificity (95% CI)
Low prevalence
NICE guidelinesc Monteny et al.[22] 20/506 99.0 100 (83.2-100) 1.03 (0.34-2.38) 0.99 (0.92-1.06) 2.11 (0.12-36.9)
NHG alarm symptomsd Van den Bruel et al. 31/3981 15.5 80.6 (62.5-92.5) 85 (83.9-86.1) 5.38 (4.46-6.49) 0.23 (0.11-0.47)
Monteny et al.[22] 20/506 94.3 100 (83.2-100) 5.97 (4.03-8.46) 1.04 (0.97-1.12) 0.39 (0.25-6.22)
Intermediate prevalence
NICE guidelinesc Brent et al.[23] 148/2777 74.5 97.3 (93.2-99.3) 26.7 (25.1-28.5) 1.33 (1.28-1.38) 0.10 (0.04-0.27)
NHG alarm symptomsd Brent et al.[23] 148/2777 80.6 100 (97.5-100) 20.5 (19.0-22.1) 1.25 (1.23-1.28) 0.02 (0.00-0.26)
High prevalence
NICE guidelinesc Thompson et al.[18] 264/700 77.3 87.1 (82.5-90.9) 28.7 (24.5-33.2) 1.22 (1.13-1.32) 0.45 (0.32-0.64)
Oostenbrink et al.[26] 260/593 98.1 98.5 (96.1-99.6) 2.10 (0.85-4.28) 1.01 (0.98-1.03) 0.73 (0.22-2.47)
NHG alarm symptomsd Thompson et al.[18] 264/700 80.6 90.9 (86.8-94.1) 25.7 (21.6-30.1) 1.22 (1.14-1.31) 0.35 (0.23-0.54)
Oostenbrink et al.[26] 260/593 98.1 98.1 (95.6-99.4) 1.80 (0.66-3.88) 1.00 (0.98-1.02) 1.07 (0.33-3.46)
 Likelihoodratio (95% CI)
positive                     negative
Probability of illness (%)
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 




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Figure 3 Results of external validation of the evidence-based clinical guidelines for management of fever. aNumber of cases (n) out of
the total population of all children (N). bPercentage testing positive in all included children. c’Traffic light’ system of clinical features that are
designed to be used to assess the risk of serious infection, and to provide clinical guidance for actions needed according to these categories.
dAlarm symptoms at clinical examination: seriously ill impression, reduced consciousness, persistent vomiting, petechiae, tachypnea and/or
dyspnea, reduced peripheral circulation, pallor, and signs of meningeal irritation; probability of illness (in percentage) before testing (blue dot),
after a positive test result (red dot with + sign) and after a negative test result (green dot with - sign).
dataset n/Na  % test positiveb % sensitivity (95% CI) % specificity (95% CI)
Low prevalence
5-stage Decision Treec Van den Bruel et al.d[7] 31/3981 12.2 96.8 (83.3-99.9) 88.5 (87.5-89.5) 8.42 (7.56-9.38) 0.04 (0.05-0.25)
Van den Bruel et al.e 31/3981 15.3 90.3 (74.2-98.0) 85.3 (84.1-86.4) 6.13 (5.34-7.03) 0.11 (0.04-0.33)
Monteny et al.[22] 20/506 57.7 90.0 (68.3-98.8) 43.6 (39.2-48.2) 1.60 (1.35-1.88) 0.23 (0.06-0.86)
Pneumonia Rulef Van den Bruel et al.d[7] 16/3981 11.0 87.5 (61.7-98.4) 89.3 (88.3-90.3) 8.18 (6.66-10.1) 0.14 (0.04-0.51)
Monteny et al.[22] 17/506 56.7 94.1 (71.3-99.9) 44.6 (40.1-49.1) 1.70 (1.47-1.96) 0.13 (0.02-0.89)
Brent et al.[23] 131/2687 60.2 92.4 (86.4-96.3) 41.4 (39.5-43.4) 1.58 (1.49-1.67) 0.18 (0.10-0.34)
Meningitis Ruleg Thompson et al.[18] 3/700 10.4 100 (29.2-100) 90.0 (87.5-92.1) 8.66 (5.63-13.3) 0.14 (0.01-1.86)
Van den Bruel et al. 9/3981 0.9 33.3 (7.49-70.1) 99.1 (98.8-99.4) 38.9 (14.6-104) 0.67 (0.42-1.07)
Yale Observation Scale (cutoff > 8 ) Monteny et al.[22] 13/482 16.6 46.2 (19.2-74.9) 84.2 (80.6-87.4) 2.93 (1.57-5.46) 0.64 (0.39-1.06)
(cutoff > 10) Monteny et al.[22] 13/482 7.3 23.1 (5.04-53.8) 93.2 (90.5-95.3) 3.38 (1.19-9.64) 0.83 (0.61-1.11)
Intermediate prevalence
5-stage Decision Treec Brent et al.[23] 148/2757 61.3 87.8 (81.5-92.6) 40.2 (38.3-42.1) 1.47 (1.37-1.57) 0.30 (0.20-0.47)
Roukema et al.[24] 216/1750 65.2 75.5 (69.2-81.0) 36.2 (33.8-38.7) 1.18 (1.09-1.29) 0.68 (0.53-0.86)
Pneumonia Rulef Roukema et al.[24] 114/1750 57.5 65.8 (56.3-74.4) 43.1 (40.7-45.5) 1.16 (1.01-1.33) 0.79 (0.61-1.03)
Bleeker et al.[25] 54/595 57 81.5 (68.6-90.7) 45.5 (41.2-49.8) 1.49 (1.29-1.73) 0.41 (0.23-0.72)
Thompson et al.[18] 67/700 12.4 26.9 (16.8-39.1) 89.1 (86.4-91.4) 2.46 (1.57-3.88) 0.82 (0.71-0.95)
Yale Observation Scale (cutoff > 8 ) Brent et al.[23] 148/2765 17.5 40.5 (32.6-48.9) 83.9 (82.3-85.2) 2.50 (2.02-3.10) 0.71 (0.62-0.81)
(cutoff > 10) Brent et al.[23] 148/2765 6.4 22.3 (15.9-29.9) 94.5 (93.6-95.3) 4.05 (2.88-5.69) 0.82 (0.75-0.90)
High prevalence
5-stage Decision Treec Bleeker et al.[25] 137/595 72.6 89.1 (82.6-93.7) 32.3 (28.0-36.8) 1.32 (1.21-1.43) 0.34 (0.21-0.56)
Thompson et al.[18] 264/700 17.1 23.0 (18.0-28.6) 86.3 (82.8-89.4) 1.68 (1.22-2.32) 0.89 (0.83-0.96)
Meningitis Ruleg Oostenbrink et al.[26] 221/593 68 95.9 (92.4-98.1) 48.7 (43.5-53.9) 1.87 (1.69-2.07) 0.08 (0.04-0.16)
Yale Observation Scale (cutoff > 8 ) Thompson et al.[18] 241/663 23.1 30.3 (24.6-36.5) 81.0 (77.0-84.7) 1.60 (1.21-2.10) 0.86 (0.78-0.95)
(cutoff > 10) Thompson et al.[18] 241/663 14.3 19.5 (14.7-25.1) 88.6 (85.2-91.5) 1.71 (1.18-2.48) 0.91 (0.85-0.98)
clinical prediction rule  Likelihoodratio (95% CI)
positive                     negative
Probability of illness (%)
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Figure 2 Results of external validation of clinical prediction rules (CPRs) to rule in or rule out serious infection. aNumber of cases (n)
out of the total population of all children (N). bPercentage testing positive in all included children. cIf yes to any of five sequential questions: 1)
clinical instinct that something is wrong, 2) dyspnea, 3) temperature greater than 39.5°C, 4) diarrhea, 5) age 15 to 29 months; dDerivation study
(italic). e’clinical instinct that something is wrong’ replaced by ‘clinical impression’. fIf yes to any of the following: 1) shortness of breath, 2)
clinicians concern. gIf yes to any of the following: 1) petechiae, 2) nuchal rigidity, 3) coma; probability of illness (in percentage) before testing
(blue dot), after a positive test result (red dot with plus to sign) and after a negative test result (green dot with minus to sign).
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whom the rules were originally designed (3 to 35 months
and up to 5 years, respectively) (see Additional file 4).
Comparing the results of the datasets in which the
complete prediction rule could be validated with those
of the datasets with one or two missing variables (five
items of the YOS, four items of the FSDT, and six items
of the NHG alarm symptoms), all diagnostic characteris-
tics were found to be similar through comparison of the
95% CIs (see Additional file 4).
By contrast, dropping ‘nuchal rigidity’ from the meningi-
tis rule resulted in a lower sensitivity (67% (95% CI 9 to
99%) versus 100% (95% CI 29 to 100%) when all three
variables were considered) in one dataset [18], eliminating
one additional dataset, which had only two out of three
original variables available, for further use in the validation
[23].
Discussion
Main findings
None of the CPRs examined in this study provided perfect
diagnostic accuracy. The best performing CPR for ruling
out serious infection in an LP setting was the FSDT,
which uses the physician’s gut feeling, the patient’s age
and temperature, and presence of dyspnea and diarrhea
[7]. Sensitivity was lower than that reported in the original
study, possibly explained by our use of ‘clinical impression’
as a proxy for ‘physician’s gut feeling’ which has been
reported to be of lower diagnostic value [3].
Both the NICE guideline and the NHG alarm symptoms
high sensitivity in both LP and IP settings, suggesting pos-
sible clinical value for ruling out serious infections in chil-
dren presenting in these settings. However, large numbers
of children were flagged as potentially having a serious
infection. If the prediction rules were to be used in clinical
practice, additional clinical assessment, additional testing,
or review at a later stage would be necessary to avoid inap-
propriate referrals or hospital admissions.
For the well-known YOS, all sensitivities were low,
which is similar to the results of a previously reported
pooled sensitivity based on the meta-analysis of seven
studies [3].
Other disease-specific rules (pneumonia and meningitis)
had acceptable sensitivities only in the LP settings, indicat-
ing value as rule-out tests. However, the percentage of
false positives was too high in all datasets, apart from one
IP dataset, probably due to the higher prevalence of pneu-
monia in this dataset [18].
Limitations
Despite the large number of datasets available, we were
able to validate only four of the eight prediction rules
plus both guidelines. The methodological challenges
encountered in performing these retrospective validations
in prospectively collected datasets limit the translation
into clinical practice. Performance of prediction rules
was generally lower than in their original derivation stu-
dies. One possible explanation for this is the approxima-
tions that we used for variables measured and recorded
in different ways (and different languages).
To avoid potential bias from validating in datasets that
were missing variables, a sensitivity analyses was per-
formed and, if findings were robust throughout the differ-
ent validation datasets, subsequent validation was deemed
suitable. In addition to variation in recorded variables,
multiple other sources of heterogeneity were found in the
included databases, including differences in setting, inclu-
sion criteria, immunization schedules, and definition of
serious infection.
Strengths
Although the limitations may be substantial, this is the
first study to externally validate existing CPRs in different
types of clinical settings. We used individual patient data
from a total of seven existing datasets comprising 11,023
children presenting to PC or EDs in three European coun-
tries to retrospectively validate existing prediction rules
and national evidence-based guidelines. Previously, only a
single prediction rule had been prospectively validated in
external datasets [11-14]. Our study therefore presents the
first robust attempt to simultaneously validate multiple
current prediction rules and evidence-based guidelines for
management of one of the most common clinical condi-
tions in AC settings. We anticipate that our findings will
be applicable to guideline developers worldwide.
Comparison with other studies
The YOS was initially developed to identify serious illness
in febrile children aged 3 to 36 months, but was subse-
quently discarded based on three prospective validation
studies (of which only one was carried out in the intended
age group) [11,13,14]. The rule was also used to stratify
patients in five studies evaluating inflammatory markers
(such as procalcitonin and C-reactive protein), with dis-
couraging results [31-35]. Bang et al. reported a slightly
better performance of the YOS in predicting bacteremia in
febrile children in an HP study (28%), which does not
apply to most AC settings [12]. Although the YOS was not
useful for ruling out a serious infection in our analysis, a
score of greater than 10 (with a combination of the pre-
sence of abnormal color or hydration status, failure to
respond to parents, different cry, and abnormal sleepiness)
did slightly increase the likelihood of a serious infection in
these datasets.
Clinical implications
With decreasing incidence of serious infections, clini-
cians will increasingly rely on CPRs in practice, particu-
larly in high-volume triage settings. In these settings,
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‘generic’ rules, which apply to all serious infections, are
more useful than disease-specific rules. Particularly in
settings where diagnosis of serious illness in children is
essential (for example, PC), the FSDT, the NICE guide-
lines, and the NHG alarm symptoms may be used to
rule out serious infections in a large proportion of chil-
dren. We suggest that the FSDT, mainly consisting of
the child’s breathing status and temperature and the
clinician’s gut feeling that something is wrong, should
be used for assessment of every acutely ill child. The
meningitis rule, with absence of nuchal rigidity, pete-
chiae, and coma, indicate that meningitis is highly unli-
kely in LP settings.
Clinicians should be aware that none of the CPRs pro-
vide perfect discrimination, and it is perhaps unrealistic to
expect such rules to provide this. Residual uncertainty
may be further improved by conducting more detailed
clinical assessments, repeating the assessment after some
time, using additional testing (for example, urine or blood
tests), and in most cases, providing an appropriate safety
netting advice for children sent home detailing instruc-
tions on when to seek further care [36].
Research implications
Most CPRs never undergo further validation or are imple-
mented, perhaps inappropriately, with insufficient external
validation [37,38]. Indeed very few CPRs for the identifica-
tion of children with serious infection have undergone
either extensive validation or formal impact analysis, limit-
ing the ability to truly evaluate their performance and to
balance benefits and harms [19,39]. In general, CPRs per-
form worse when validated in new populations [40].
Our study presents the first multiple external validation
of CPRs in this common clinical area, and identifies which
of them offer the best diagnostic accuracy in different
types of clinical settings. This illustrates the clear need to
perform extensive prospective validation and impact ana-
lysis of CPRs prior to clinical implementation [39,41]. The
FSDT and the NICE guidelines for assessment of feverish
children are potential candidates for future prospective
validation studies examining their performance in new
prospectively collected data on similar populations.
We recognize the previously identified major mismatch
[3], between the clinical settings where the majority of
children with acute infections seek help (that is, PC), and
the number of studies performed in that setting (two stu-
dies) (Table 2). There is a pressing need for more studies
conducted in PC or in LP ED settings to validate CPRs for
serious infection, or the need for hospital referral/admis-
sion. Given the relative infrequency of serious infections,
such studies need to include large cohorts of children
[7,8]. CPRs are mostly designed to rule out serious infec-
tions, often at the expense of moderate to low ability for
inclusion. As no rule is perfect at ruling out infection,
research on the most effective content and methods of
delivery with appropriate safety netting advice in PC and
EDs is essential [8,36,42]. Adding newer tests such as
point-of-care inflammatory markers may improve the
diagnostic value of these rules, but the performance of
these markers in non-referred populations has to be tested
[43].
Conclusions
None of the CPRs examined in this study provided per-
fect diagnostic accuracy. In LP settings (for example,
PC) or IP settings, prediction rules, such as the FSDT
and evidence-based guidelines (NICE guideline and the
NHG alarm symptoms) had high sensitivity, providing
promising rule-out value for serious infections in these
datasets, although all seemed to leave residual uncer-
tainty. Additional clinical assessment or testing such as
point-of-care inflammatory markers may be needed to
increase clinical certainty. None of the prediction rules
identified seemed to be valuable for HP settings (for
example, EDs).
Additional material
Additional file 1: Details of the clinical prediction rules identified in
the systematic review. CRT, capillary refill time; RR, respiratory rate;
Temp, temperature.
Additional file 2: variables and proxies used for validation of
clinical prediction rules. N = Number of children in dataset; % n/N =
Percentage of cases (n) out of all children (N) used for the external
validation analysis; green font indicate original variable, red font,variable
not recorded, blue font, proxy variable. aDerivation study (italic). b’Clinical
sick impression’ used as proxy for ‘physician’s gut feeling that something
is wrong’, c’Respiratory distress’ used as proxy for ‘dyspnoea’. d’Chest
flaring’ used as proxy for ‘dyspnoea’. e’Meningeal irritation’ used as proxy
for ‘nuchal rigidity’. f’Unconsciousness’ used as proxy for ‘coma’.
Additional file 3: Variables and proxies used for fever guidelines
validation. N. number of children in dataset; % n/N. percentage of cases
(n) out of all children (N) used for the external validation analysis; green
font. original variable
Additional file 4: Sensitivity analyses. CI, confidence interval;
underlined, 95% CIs not comparable.
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